At the request of the Company, trading in Phytopharm's Premium listed shares on the Main Market of the London Stock Exchange has been suspnded. Please see the press release

Phytopharm Suspension Announcement

Should you require further information or have any queries please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it